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satisfaction questions revealed that 73.2% of patients would 
retrospectively elect to have the procedure again. We report 
two postoperative complications in this group of superfi-
cial wound infections. Radiographically, all MCPJs showed 
improved alignment, however five patients reported wors-
ening pain, four patients reported increased stiffness and 
four reported reduced function postoperatively. There was 
one re-operation of a 5th MCPJ Swanson’s, which did not 
require implant exchange and one implant was revised. 
Implant survivorship was 98.6%.
Conclusions Patient satisfaction and functional surrogate 
markers were overall favourable. Our results support the 
continued use of Swanson silastic arthoplasty in advanced 
RA.
Keywords Swanson · Metacarpo-phalangeal joint · 
Silastic implants · M-SACRAH · Patient-reported outcome 
measures · Rheumatoid arthritis
Introduction
It is estimated that approximately 600,000 people in the 
United Kingdom are affected by rheumatoid arthritis. 
A prevalence study reports that the disease effects 1% of 
men and 3% of women worldwide [1]. Rheumatoid arthri-
tis is a symmetrical inflammatory poly-arthropathy char-
acterised by progressive cell-mediated destruction of the 
joints, with early predisposition for the small joints of the 
hands and feet. The metacarpophalangeal joint (MCPJ) is 
the most commonly involved joint in the hand and is seen 
early in the disease process [2]. Although the aetiology 
of the deformity is not fully understood, a proliferative 
and destructive synovitis of the articular surfaces with a 
loss of supporting structures of the joint is thought to be 
Abstract 
Introduction Replacement of the metacarpo-phalangeal 
joints (MCPJ) with silastic Swanson’s implants can help 
decrease pain, stiffness and allow for improved function 
in rheumatoid arthritis (RA). There is a lack of patient 
reported outcome measure (PROM) studies assessing the 
efficacy of this procedure in RA. The aim of this study was 
to report any change in function, pain, stiffness and satis-
faction following the Swanson MCPJ replacement using 
patient reported outcomes in a rheumatoid population.
Methods The combined results of 64 RA patients (71 
hands) with 284 Swanson MCPJ arthroplasties (mean fol-
low-up: 75.85  months) were assessed using the validated 
M-SACRAH questionnaire and a separate satisfaction 
questionnaire. Radiographic evaluation was performed to 
insure correct alignment of the hinged prosthesis postop-
eratively. No attempt was made to identify other predic-
tors, radiologically or clinically. Data analysed in the study 
was interpreted in the context of the number of hands and 
survivorship was defined as implant fracture, loosening or 
revision.
Results The mean total functional outcome score 
improved by 46.2% and the total pain outcome improved 
by 60.2%. The total stiffness outcome improved by 
56.9% postoperatively and the results obtained from the 
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the driving mechanism of deformity. The end stage rheu-
matoid MCPJ is classically subluxed or dislocated vol-
arly, fixed in flexion with ulnar deviation of the fingers 
(Fig.  1) [3]. Unfortunately, however RA is not limited to 
the MCPJ articulation and the classic wrist collapse leads 
to radial deviation of the metacarpals, further exaggerat-
ing the deforming forces acting upon the MCPJ [3]. As a 
result of these processes patients can develop intractable 
pain, reduced function and progressive deformity incom-
patible with daily living. The National Institute for Health 
and Clinical Excellence (NICE) guidelines emphasise the 
importance of early introduction of disease modifying anti-
rheumatic drugs (DMARD), often combined with the use 
of biological therapies [4]. Though becoming less common 
with early aggressive medical management, surgical inter-
vention is indicated when there is persistent pain, synovi-
tis, worsening function or progressive deformity despite 
optimal medical therapy [5]. Replacement of the MCPJ 
is a well-established procedure and the most widely used 
implant utilises silastic flexible hinge prosthesis [6].
Silicone implants have been used since the late 1960s to 
replace destroyed MCPJs in the rheumatoid hand. Swanson 
first described MCPJ replacement using a hinged, double 
stemmed silicone implants in 1969. This has emerged as 
the preferred, most commonly used implant because of its 
durability and flexibility [7]. The most common indication 
for Swanson’s arthoplasty of the MCPJ in RA is pain and 
loss of function in the late stage deformity [6, 8]. Other 
implants which can be used include the unconstrained two 
piece pyrolytic carbon implants but are not regularly used 
due to expense and concern with their ability to resist flex-
ion and ulnar deviation forces in comparsion with their sili-
cone counterparts [3].
Although radiological and physical outcomes are clearly 
important in assessing biomechanical changes [2] they 
have limited bearing unless they are considered in context 
of the patients perceived benefit in terms of reducing pain, 
stiffness, improving function and ultimately quality of life. 
However, relatively little is known in relation to patient-
reported outcomes after Swanson’s MCPJ replacement. 
The objectives of this study were to report any change in 
patient reported outcomes of function, stiffness and pain 
following the Swanson MCPJ arthroplasty in a two senior 
surgeon series of rheumatoid patients using the validated 
Modified-score for the assessment and quantification of 
chronic affections of the hand (M-SACRAH) questionnaire 
[9]. A separate questionnaire was used to assess general 
satisfaction following the procedure. We are aware of only 
one other smaller prospective outcomes study assessing 
efficacy of this procedure [10]. The intent of this report was 
not to necessarily evaluate the Swanson implant per se, but 
to evaluate the effectiveness from the patient’s perspective 
which could be used to provide useful quantitative data and 
information for patient counselling.
Materials and methods
From our local arthroplasty database of two senior sur-
geons over an 18  year period, 64 patients (71 hands) 
with long standing RA who had undergone the Swan-
son 2–5 MCPJ arthroplasty (284 implants) were identi-
fied. The mean follow-up period was 75.85 months (range 
3–207) months. One patient died from unrelated causes to 
the procedure and was lost to follow-up. All arthroplas-
ties were performed in the same hospital by one of two 
senior consultant surgeons (SJB, CRH) and routinely on 
the end stage rheumatoid hand (Larsen grade 4 or 5) using 
the same surgical technique (though slightly modified) 
and postoperative management as described by Swanson 
[6]. The primary outcome measures were the same for all 
patients and included the validated M-SACRAH score and 
a separate departmental satisfaction questionnaire. The 
M-SACRAH is a validated 12-point questionnaire assess-
ing the rheumatoid hand in three domains: (1) hand func-
tion (eight questions):‘possible without any difficulty’ (0) 
to ‘impossible’ (100); (2) stiffness (two questions), using a 
range from ‘no stiffness’ (0) to ‘unbearable stiffness’ (100); 
(3) pain (two questions), using a range from ‘no pain’ (0) to 
‘unbearable pain’ (100).
After gaining verbal consent, patients were asked to 
complete the M-SACRAH questionnaire assessing preoper-
ative and postoperative level of pain, stiffness and function. 
This study was largely prospective in its data collection, but 
some data had to be collected retrospectively. Patients oper-
ated on or after 2010 had their preoperative questionnaires 
Fig. 1  The end stage rheumatoid MCPJ is classically subluxed or 
dislocated volarly, fixed in flexion with ulnar deviation of the fingers. 
Left hand 4 years postpostoperatively, right hand prior surgery
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collected prospectively at preassessment clinic using the 
M-SACRAH. Prior to 2010 the author’s own prospective 
data recording in patient medical notes provided the data 
for the preoperative M-SACRAH questions. Any outstand-
ing (10 out of 12 questions; function 1/8 locking/unlock-
ing a door and 8/8 writing by hand) questions hence had to 
be obtained in a retrospective manner to allow comparative 
M-SACRAH scoring.
In addition, patients were asked to answer three individ-
ual satisfaction related questions: (1) overall how pleased 
have you been with the results of your surgery so far? 
(Very pleased, fairly pleased, not very pleased, very dis-
appointed), (2) in hindsight, would you still elect to have 
the procedure done? (Yes/Maybe/No), (3) would you rec-
ommend this procedure? (Yes/Maybe/No). Radiographic 
evaluation was performed to insure correct alignment of 
the hinged prosthesis postoperatively. No attempt was made 
to identify other predictors, radiologically or clinically and 
data analysed in the study was interpreted in the context of 
the number of hands. The aim of this study was to assess 
the success and overall satisfaction following the Swanson 
MCP arthroplasty using patient reported outcomes. Post-
operative complications including infection, re-operation, 
stiffness as well as implant survival rate were determined. 
Survivorship was defined as implant fracture, loosening or 
revision. Statistical comparisons were performed in Excel 
using two-sided paired Student’s t test examining outcomes 
before and after surgery. Differences were deemed statisti-
cally significant if the p-value was <0.05.
Surgical technique
All procedures were performed by the senior surgeons 
(CRH or SJB) in accordance (although albeit slightly modi-
fied) with the technique described by Swanson [6]. General 
anaesthetic and nerve block, 1.5 g IV Cefuroxime at induc-
tion, above elbow tourniquet. A transverse dorsal skin inci-
sion was made from 2nd to 5th MC heads to allow access 
to all MCPJs. The dislocated extensor hood was released 
laterally with release of paratendon along the full length 
of the proximal phalanx extending proximally to the MCs. 
The extensor tendon was then retracted medially to expose 
the joint for synovectomy, release of the ulnar collateral 
ligaments at the 5th digit and release of abductor digiti 
minimi. Full synovectomy, exposure and sharp capsular 
release of the metatarsal head and base of proximal phalanx 
was required to allow correction of volar flexion and ulnar 
deviation contractures. After resection of the MC head a 
full capsular release was then possible. After osteotomy 
of the proximal phalanx base both the MC and phalanx 
intramedullary cavities were reamed and prepared using 
small hand broaches to ensure tight canal fit of the trial 
implants. The largest possible implant was used and reefing 
of radial collateral with trans-osseous non-absorbable Ethi-
bond sutures was done. If necessary further Vicryl reefing 
sutures were used to ensure relocation and fixation of the 
extensor tendons. Washout, haemostasis, skin closure and 
tourniquet released. Gauze dressing, cotton wool band-
age and crepe bandage. Volar slab with hand in functional 
position. All patients routinely had X-rays and cefuroxime 
IV postoperatively. Wound inspection at day 4–6 postop-
eratively at first physiotherapy appointment as per local 
integrated care pathway. The postoperative physiotherapy 
programme included night splinting and regular exercise 
session for up to 3  months [11]. Figure  2 demonstrates 
the postoperative radiographic appearance of the Swanson 
silastic MCPJ arthroplasty.
Results
One patient had died at the time of follow-up from causes 
unrelated to the surgery. The baseline characteristics are 
outlined in Table 1.
Outcomes
Highly significant improvements in all domains of func-
tion, pain and stiffness scores were reported following 
Fig. 2  The postoperative radiographic appearance of the Swan-
son silastic MCPJ arthroplasty. Radiographs show no evidence for 
implant failure
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the Swanson MCPJ arthroplasty. The majority of patients 
reported improvement in all areas, however individual 
variation in response to surgery was observed with five 
patients reporting moderately worsening of pain, four 
patients reporting a deteriorating function due to stiffness 
and four patients reported worsening stiffness postopera-
tively. One patient reporting no change in stiffness, how-
ever this did not correlate with deteriorating function. 
Overall there is a remarkable uniformity in the observed 
reported outcomes. Summary of the results for all inter-
ventions is reported in Table  2. In keeping with these 
positive results very high levels of overall satisfaction 
were observed with 73.2% of patients reporting that they 
would retrospectively elect to have the procedure again 
and 84.5% would recommend the procedure, with the 
majority of patients being “very pleased” with the out-
come of their surgery (58% “very pleased”, 28.2% “fairly 
pleased” and 14% “dissatisfied”).
Complications and radiographs
We report two postoperative complications in this group of 
superficial wound infections in patients on Methotrexate, 
which resolved with a course of oral antibiotics. There was 
one re-operation of a 5th MCP Swanson’s due to delicate 
soft tissue coverage and worry of skin breakdown. At re-
operation the Swanson was not exchanged but the Silicon 
ridge laterally was trimmed with a knife. One implant was 
Table 1  Baseline 
characteristics of the study 
population
Demographics n = 71
Gender Female (60), male (11)
Age (years); mean (range) 63.2 (42–83)
Procedure on dominant hand 44 (62%)
Follow-up (months) mean (range) 75.85 (2-207)
Mean disease duration (range) 9.13 years (2–12)
Disease modifying therapies (%) Methotrexate (42.2%), None (23.9%), Etanercept (7%), Hydroxychlo-
roquine (9.9%), Azathioprine (7%), Sulfasalazine (8.4%) Lefluno-
mide (8.4%) Rituximab (4.2%)
Polyarticular disease 58 (81.7%)
Table 2  Function, stiffness and pain outcomes of the M-SACRAH questionnaire
Bold values indicate statistically significant
Consistent and highly significant improvements across all outcomes are reported following the Swanson MCPJ arthroplasty in all parameters 
assessed. P values represent the result of paired Student’s t test comparing pre- and postoperative scores
Preoperative mean (range) Postoperative mean (range) % Improvement P value
Function
 Locking/unlocking a door 78.6 (10–100) 42.1 (0–100) 46.4 <0.001
 Buttoning up/unbuttoning shirt/blouse 84.5 (10–100) 46.3 (0–100) 45.2 <0.001
 Turning a water tap 80.4 (20–100) 43.1 (0–100) 46.4 <0.001
 Fastening/unfastening a zip 81.9 (20–100) 45.9 (0–100) 43.9 <0.01
 Tying shoelaces 85.5 (40–100) 45.3 (0–100) 47 <0.001
 Unscrewing a toothpaste cap 80.4 (20–100) 43.2 (0–100) 46.3 <0.001
 Turning the pages of a newspaper 62.95 (0–100) 30.8 (0–90) 51.1 <0.001
 Writing by hand 78.45 (10–100) 43.5 (10–100) 44.5 <0.001
 Total 632.8 (300–800) 340.4 (90–780) 46.2 <0.001
Stiffness
 Morning stiffness 83.7 (30–100) 34.64 (0–100) 58.6 <0.001
 Stiffness later in day following inactivity 75.35 (20–100) 31.8 (0–100) 57.8 <0.001
 Total 159 (50–200) 68.5 (0–200) 56.9 <0.001
Pain
 Pain during intensive work 81.3 (10–100) 36.1 (0–100) 55.6 <0.001
 Pain at times of inactivity 72.2 (20–100) 25.1 (0–90) 65.2 <0.001
 Total 153.5 (50–200) 61.1 (0–180) 60.2 <0.001
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revised at 9 years due to clinically evident silicon synovi-
tis. Radiographically, all MCPJs showed good anatomical 
alignment at the scheduled 1 year follow-up with no signifi-
cant recurrent ulnar deviation (>10°). Thirty-three patients 
did not have up to date radiographs for assessment. There 
was radiographic evidence confirming three implant frac-
tures (4.22%), however these did not require revision as 
there was no clinical evidence of silicone synovitis.
Discussion
The Swanson’s arthoplasty technique offers excellent 
immediate results with reduction in pain, improvement of 
arc of motion and correction of the deformity [12]. Despite 
the long term use of the Swanson implants, the current 
evidence-based literature assessing this procedure in RA is 
limited, consisting mostly of retrospective case series that 
are predominantly based on radiological and physical out-
comes such as grip strength and range of motion or report 
on other patient groups [13]. The limited long-term studies 
that have been published demonstrate a high rate of implant 
failure due to fracture (up to 58%) or loosening of the silas-
tic implants [13, 14]. The definition of loosening is obscure 
as these silicone implants are by definition never firmly 
fixed or ingrown. The main failure mechanisms are frac-
ture and silicone wear leading to synovitis, both of which 
we encountered in our series. The implant fracture rate was 
apparently low, but some implant fractures may have been 
missed, as 33/64 patients had no up to date radiographs 
at time of follow-up, which is the main limitation of our 
study. Despite this radiographic failure; Swanson’s MCPJ 
arthroplasty has remained a popular procedure [2, 3, 5, 6]. 
There is however limited information available regarding 
the long-term clinical outcome of Swanson MCPJ in this 
patient group with only one study assessing the long-term 
outcome of silicone MCPJ, which did not report exclu-
sively on the Swanson prosthesis [15].
Although patient-reported outcome measure (PROM) 
studies are becoming more fashionable in assessing the 
effectiveness of surgical procedures, we are aware of only 
one other study in the published literature that reports on 
the effectiveness of this procedure using PROM’s. Our 
results compare well with other studies reporting favour-
able results in the short term [6, 16–18]. The fact that 
some of the data for the validated questionnaire had to be 
obtained retrospectively has to be regarded as a significant 
limitation of our study, but we still feel that as the major-
ity of data was collected in a prospective manner, that our 
findings are of clinical value. Patient expectations of MCP 
joint arthroplasty are high [19] and our results may be used 
by rheumatologists and surgeons to provide better patient 
counselling and help set realistic expectations. A study of 
33 patients with RA who received silicone MCPJ arthro-
plasty concluded that the greatest motivation for surgery 
was functional improvement with pain reduction ranked 
second. In addition to this they reported that aesthetic 
appearance should also be considered an important moti-
vation for surgery and determinant of satisfaction in MCP 
joint arthroplasty in RA [19]. A prospective study of 137 
patients compared the expectations and outcomes of func-
tion and pain for surgical (silicon MCPJ arthroplasty) and 
non-surgical (medically managed) RA patients over an 
average follow-up period of 6.7  years. Their report high-
lighted that although patients tended to be over-optimistic 
about the outcome of surgery; overall a higher proportion 
of surgical patients were more satisfied with their treatment 
and had greater levels of hand function at long-term follow-
up [20].
An additional important factor in hand biomechanics 
that makes silicon MCPJ challenging is that it is difficult 
to evaluate each joint in isolation because there is substan-
tial interplay between adjacent joints in the hand with some 
advocating evaluation of surrounding joints before planning 
silicon MCPJ arthroplasty [21]. Two of the more common 
hand deformities in RA are swan neck and boutonniere 
deformities. It had been postulated in the past that bouton-
niere deformity as having a detrimental effect on MCPJ arc 
of motion thus requiring correction prior to MCPJ arthro-
plasty. In contrast, proximal interphalangeal joint hyperex-
tension in the swan neck deformity creating greater need 
for metacarpophalangeal joint motion to make a fist thus, 
recommending delaying the treatment after silicone meta-
carpophalangeal joint arthroplasty. One group tested this 
hypothesis by assessing the arc of motion in 73 rheumatoid 
MCP joints as well as functional hand outcomes using the 
Michigan hand outcomes questionnaire. Their study did not 
support the theory that boutonniere deformity has nega-
tive effects on MCPJ arc of motion despite having worse 
baseline function. They also reported that RA patients with 
swan neck deformities did not have a greater MCPJ arc of 
motion before or after surgery, thus concluding that MCPJ 
arthroplasty should be performed before treatment of swan 
neck or boutonniere deformities [22].
In the cohort analysed in this study, patients reported 
an overall decrease in pain with the majority (58%) very 
pleased and most (84.5%) would retrospectively have the 
procedure performed again. These favourable satisfaction 
outcomes have been echoed by other studies in the pub-
lished literature [23, 24]. Patient pain and functional surro-
gate markers were also overall very favourable. Noticeable 
individual variation in response to surgery was observed 
with four patients in this group reporting a substantial 
loss of function postoperatively and five patients reporting 
moderately worsening of pain following their procedure. 
It is important to note that all these patients had longer 
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disease duration, severe baseline polyarticuar disease (90% 
Larsen grade 5) and longer follow-up period compared to 
other patients in this group. Therefore the inferior results at 
longer term follow-up may merely represent gradual dete-
riotion over time with ageing and RA progression. A lon-
gituninal study with regular follow-up interval recordings 
would be required to determine this relationship and this 
has now been implemented in the one of the authors pro-
spective sub-cohort of patients. Despite this apparent func-
tional loss however; it has been demonstrated that patient 
satisfaction improves after silicone MCPJ arthroplasty 
despite minimal change in hand function. One prospec-
tive, multicentre study that examined the intersect between 
functional outcomes and patient satisfaction concluded that 
clinically successful MCPJ replacement does not need to 
fully restore the full ROM of the joint in the rheumatoid 
hand. In their report MCPJ arthroplasty did not increase 
ROM however this was not associated with any adverse sat-
isfaction outcomes [25].
Despite the limitations in observational studies of this 
kind we still feel that overall there is a remarkable uniform-
ity in the observed reported outcomes suggesting the Swan-
son MCPJ replacement to be an effective procedure in this 
patient population with mainly favourable results in terms 
of reduction in stiffness, pain, improvements in function 
and good satisfaction results. In our opinion therefore this 
procedure should still be considered as a viable option in 
management of rheumatoid patients with intractable pain 
and progressive loss of hand function.
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